Valiant Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 58.42 | 35.89 | 23.41 |
| Operating Expense | 53.94 | 34.60 | 28.22 |
| Net Profit | 3.24 | 1.60 | -5.98 |
| Net Profit Margin | 5.55 | 4.46 | -25.54 |
| Earning Per Share | 0.74 | 0.37 | -1.39 |
| EBIDTA | 3.86 | 2.17 | -5.55 |
| Effective Tax Rate | 1.34 | TBA | 1.87 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 58.42 |
| Operating Expense | 53.94 |
| Net Profit | 3.24 |
| Net Profit Margin | 5.55 |
| Earning Per Share | 0.74 |
| EBIDTA | 3.86 |
| Effective Tax Rate | 1.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 182.05 | 333.91 | 291.52 |
| Operating Expenses Annual | 190.46 | 298.82 | 249.20 |
| Operating Profit Annual | 1.27 | 39.95 | 44.27 |
| Interest Annual | 0.08 | 0.25 | 0.07 |
| Depreciation | 1.95 | 1.56 | 2.49 |
| Net Profit Annual | 0.34 | 29.00 | 27.50 |
| Tax Annual | -1.09 | 9.14 | 14.21 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 182.05 |
| Operating Expenses Annual | 190.46 |
| Operating Profit Annual | 1.27 |
| Interest Annual | 0.08 |
| Depreciation | 1.95 |
| Net Profit Annual | 0.34 |
| Tax Annual | -1.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.38 | 0.13 | 3.94 |
| Cash Flow from Operations | 48.78 | 22.96 | 2.25 |
| Cash Flow from Investing | -182.73 | -21.18 | -12.24 |
| Cash Flow from Financing | 135.80 | -1.53 | 6.18 |
| Cash Flow at the End | 2.23 | 0.38 | 0.13 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.38 |
| Cash Flow from Operations | 48.78 |
| Cash Flow from Investing | -182.73 |
| Cash Flow from Financing | 135.80 |
| Cash Flow at the End | 2.23 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -1.05 | 11.96 | 15.18 |
| PBIT Margin (%) | -2.13 | 11.50 | 14.33 |
| PBT Margin (%) | 24.45 | -34.49 | -190.41 |
| Net PROFIT Margin (%) | 0.19 | 8.68 | 9.43 |
| Return On Networth / Equity (%) | -1.70 | 33.73 | 34.37 |
| Return On Networth /Employed (%) | -1.68 | 26 | 37.35 |
| Return On Assets (%) | 0.15 | 19.63 | 24.62 |
| Total Debt / Equity (X) | 0.36 | 0.71 | 0.39 |
| Asset Turnover Ratio (%) | 0.79 | 2.26 | 2.61 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -1.05 |
| PBIT Margin (%) | -2.13 |
| PBT Margin (%) | 24.45 |
| Net PROFIT Margin (%) | 0.19 |
| Return On Networth / Equity (%) | -1.70 |
| Return On Networth /Employed (%) | -1.68 |
| Return On Assets (%) | 0.15 |
| Total Debt / Equity (X) | 0.36 |
| Asset Turnover Ratio (%) | 0.79 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 31.61 | 29.97 | 22.23 |
| Total Current Assets Annual | 209.27 | 181.96 | 156.80 |
| Non Current Assets Annual | 115.46 | 30.80 | 25.02 |
| Total Shareholders Funds Annual | 236.88 | 100.49 | 71.46 |
| Total Assets Annual | 324.73 | 212.76 | 181.81 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 31.61 |
| Total Current Assets Annual | 209.27 |
| Non Current Assets Annual | 115.46 |
| Total Shareholders Funds Annual | 236.88 |
| Total Assets Annual | 324.73 |
EPS (INR)
Expected
0.16
Reported
0.16
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
